Tronox Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 21, 2017 - Press Releases
performance was driven by higher production volumes, lower operating costs and increased production efficiencies. Our cash generation performance further strengthened our balance sheet, as we closed the quarter with
Casey continued, “We have said that 2016 marked the recovery in global TiO2 markets. Our strong performance in the fourth quarter continued to provide strong evidence of that. We expect the momentum generated last year to continue in 2017 based on our belief that pigment inventories, in the aggregate, are at or below normal levels at both customer and producer locations across the globe resulting in a continued tight supply-demand balance.”
The Tronox Board of Directors declared quarterly dividend of
Fourth Quarter 2016
Tronox TiO2
TiO2 segment revenue of
than year-ago levels. Sales volumes for natural rutile were 29 percent lower while selling prices increased 6 percent. Pig iron sales volumes were 24 percent lower and selling prices increased 3 percent.
Compared sequentially, TiO2 segment revenue of
million
TiO2 segment adjusted EBITDA of
TiO2 segment income from operations of
Alkali segment revenue of
typically lag price increases in its domestic market.
Compared sequentially, Alkali revenue of
Alkali segment adjusted EBITDA of
Alkali segment income from operations of
Corporate
Corporate loss from operations was
Consolidated
Selling, general and administrative expenses were
Full Year 2016
For the full-year 2016, revenue was
Tronox TiO2
TiO2 segment revenue of
Alkali segment revenue of
expenditures of
Corporate
Corporate loss from operations was
Consolidated
Selling, general and administrative expenses for the year were
Webcast Conference Call
Internet Broadcast: https://www.tronox.com/
Dial-in telephone numbers:
International: +1.253.237.1184
Conference ID: 60414852
Conference Call Presentation Slides will be used during the conference call and are available on our website at https://www.tronox.com/
Webcast Conference Call Replay: Available via the
Internet Replay: www.tronox.com
Replay dial-in telephone numbers:
International: +1.404.537.3406
Conference ID: 60414852
Upcoming Conferences
During the first quarter 2017 a member of management is scheduled to present at the following conferences:
Alembic Global Chemicals Conference ,Deer Valley , UT,March 2-3, 2017 - Goldman Sachs Chemicals Intensity Day,
Houston ,March 21, 2017 Barclays Materials ROC Stars Conference ,New York ,March 29, 2017
Accompanying conference materials will be available at http://investor.tronox.com
About
Forward Looking Statements
Statements in this release that are not historical are forward-looking statements within the meaning of the
filings with the
Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all risks and uncertainties, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Unless otherwise required by applicable laws, we
undertake no obligation to update or revise any forward-looking statements, whether as a result of new information or future developments.
Use of Non-
To provide investors and others with additional information regarding
other companies. The non-
Management believes these non-
Reflect Tronox Limited’s ongoing business in a manner that allows for meaningful period-to-period comparison and analysis of trends in its business, as they exclude income and expense that are not reflective of ongoing operating results;- Provide useful information to investors and others in understanding and evaluating
Tronox Limited’s operating results and future prospects in the same manner as management and in comparing financial results across accounting periods; - Provide additional view of the operating performance of the company by adding interest expenses, taxes, depreciation, depletion and amortization to the net income. Further adjustments due to purchase accounting and stock-based compensation charges attempt to exclude items that are either non-cash or unusual in nature;
- Assist investors to assess the company’s compliance with financial covenants under its debt instruments;
- Adjusted EBITDA is one of the primary measures management uses for planning and budgeting processes and to monitor and evaluate financial and operating results. Adjusted EBITDA is not a recognized term under
U.S. GAAP and does not purport to be an alternative to measures of our financial performance as determined in accordance withU.S. GAAP, such as net income (loss). Because other companies may calculate EBITDA and Adjusted EBITDA differently thanTronox , EBITDA may not be, and Adjusted EBITDA as presented in this release is not, comparable to similarly titled measures reported by other companies, and - We believe that the non-
U.S. GAAP financial measure “Adjusted net loss attributable toTronox Limited ” and its presentation on a per share basis provide useful information about our operating results to investors and securities analysts. We also believe that excluding the effects of these items from operating results allows management and investors to compare more easily the financial performance of our underlying businesses from period to period.
Media Contact:
Investor Contact:
|
|||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS (US GAAP) |
|||||||||||||
(UNAUDITED) |
|||||||||||||
(Millions of |
|||||||||||||
Three Months Ended |
Year Ended |
||||||||||||
2016 |
2015 |
2016 |
2015 |
||||||||||
Net sales |
$ 548 |
$ 535 |
$ 2,093 |
$ 2,112 |
|||||||||
Cost of goods sold |
458 |
513 |
1,846 |
1,992 |
|||||||||
Gross profit |
90 |
22 |
247 |
120 |
|||||||||
Selling, general, and administrative expenses |
(59) |
(46) |
(210) |
(217) |
|||||||||
Restructuring expense |
1 |
(14) |
(1) |
(21) |
|||||||||
Income (loss) from operations |
32 |
(38) |
36 |
(118) |
|||||||||
Interest and debt expense, net |
(46) |
(45) |
(184) |
(176) |
|||||||||
Gain on extinguishment of debt |
– |
– |
4 |
– |
|||||||||
Other income (expense), net |
(6) |
6 |
(29) |
28 |
|||||||||
Loss before income taxes |
(20) |
(77) |
(173) |
(266) |
|||||||||
Income tax benefit (provision) |
144 |
(12) |
115 |
(41) |
|||||||||
Net income (loss) |
124 |
(89) |
(58) |
(307) |
|||||||||
Net income attributable to noncontrolling interest |
2 |
1 |
1 |
11 |
|||||||||
Net income (loss) attributable to |
$ 122 |
$ (90) |
$ (59) |
$ (318) |
|||||||||
Income (loss) per share: |
|||||||||||||
Basic |
$ 1.04 |
$ (0.78) |
$ (0.50) |
$ (2.75) |
|||||||||
Diluted |
$ 1.00 |
$ (0.78) |
$ (0.50) |
$ (2.75) |
|||||||||
Weighted average shares outstanding (in thousands): |
|||||||||||||
Basic |
116,319 |
115,673 |
116,161 |
115,566 |
|||||||||
Diluted |
120,881 |
115,673 |
116,161 |
115,566 |
|||||||||
Other Operating Data: |
|||||||||||||
Capital expenditures |
$ 32 |
$ 50 |
$ 119 |
$ 191 |
|||||||||
Depreciation, depletion and amortization expense |
$ 61 |
$ 72 |
$ 236 |
$ 294 |
|
||||||||
RECONCILIATION OF NON- |
||||||||
(UNAUDITED) |
||||||||
(Millions of |
||||||||
RECONCILIATION OF NET LOSS |
||||||||
ATTRIBUTABLE TO TRONOX LIMITED ( |
||||||||
TO ADJUSTED NET LOSS |
||||||||
ATTRIBUTABLE TO TRONOX LIMITED (NON- |
||||||||
Three Months Ended |
Year Ended |
|||||||
2016 |
2015 |
2016 |
2015 |
|||||
Net income (loss) attributable to |
$ 122 |
$ (90) |
$ (59) |
$ (318) |
||||
Acquisition related matters (a) |
– |
– |
– |
36 |
||||
Restructuring expense (b) |
(1) |
14 |
1 |
21 |
||||
Gain on extinguishment of debt (c) |
– |
– |
(4) |
– |
||||
Tax impact of reorganization (d) |
(137) |
– |
(107) |
– |
||||
Adjusted net loss attributable to |
$ (16) |
$ (76) |
$ (169) |
$ (261) |
||||
Diluted income (loss) per share attributable to |
$ 1.00 |
$ (0.78) |
$ (0.50) |
$ (2.75) |
||||
Acquisition related expense, per share |
– |
– |
– |
0.31 |
||||
Restructuring expense, per share |
(0.01) |
0.12 |
0.01 |
0.18 |
||||
Gain on extinguishment of debt, per share |
– |
– |
(0.03) |
– |
||||
Tax impact of reorganization, per share |
(1.13) |
– |
(0.92) |
– |
||||
Diluted adjusted loss per share attributable to |
$ (0.14) |
$ (0.66) |
$ (1.44) |
$ (2.26) |
||||
Weighted average shares outstanding, diluted (in thousands) |
120,881 |
115,673 |
116,161 |
115,566 |
(a) One-time non-operating items and the effect of acquisition. During 2015, transaction costs consist of costs associated with the acquisition of the Alkali business, including banking, legal and professional fees. During the year ended |
||||||||
(b) Represents severance costs associated with the shutdown of our sodium chlorate plant and other global |
||||||||
(c) Represents the gain associated with the repurchase of |
||||||||
(d) Represents the benefit of corporate reorganization recorded in the unaudited Consolidated Statements of Operations. For the three months ended |
||||||||
(e) No income tax impact given full valuation allowance except for |
|
||||||||
SEGMENT INFORMATION |
||||||||
(UNAUDITED) |
||||||||
(Millions of |
||||||||
Three Months Ended |
Year Ended |
|||||||
2016 |
2015 |
2016 |
2015 |
|||||
TiO2segment |
|
|
|
|
||||
Alkali segment |
196 |
199 |
784 |
602 |
||||
Net sales |
|
|
|
|
||||
TiO2segment |
$ 18 |
$ (65) |
$ 6 |
$ (123) |
||||
Alkali segment |
30 |
23 |
84 |
69 |
||||
Corporate |
(16) |
4 |
(54) |
(64) |
||||
Income (loss) from operations |
32 |
(38) |
36 |
(118) |
||||
Interest and debt expense, net |
(46) |
(45) |
(184) |
(176) |
||||
Gain on extinguishment of debt |
– |
– |
4 |
– |
||||
Other income (expense), net |
(6) |
6 |
(29) |
28 |
||||
Loss before income taxes |
(20) |
(77) |
(173) |
(266) |
||||
Income tax benefit (provision) |
144 |
(12) |
115 |
(41) |
||||
Net income (loss) |
124 |
(89) |
(58) |
(307) |
||||
Net income attributable to noncontrolling interest |
2 |
1 |
1 |
11 |
||||
Net income (loss) attributable to |
|
$ (90) |
$ (59) |
$ (318) |
|
||||||||
CONSOLIDATED BALANCE SHEETS |
||||||||
(UNAUDITED) |
||||||||
(Millions of |
||||||||
|
|
|||||||
ASSETS |
2016 |
2015 |
||||||
Current Assets |
||||||||
Cash and cash equivalents |
$ 248 |
$ 229 |
||||||
Restricted cash |
3 |
5 |
||||||
Accounts receivable, net of allowance for doubtful accounts |
421 |
391 |
||||||
Inventories, net |
532 |
630 |
||||||
Prepaid and other assets |
49 |
46 |
||||||
Total current assets |
1,253 |
1,301 |
||||||
Noncurrent Assets |
||||||||
Property, plant and equipment, net |
1,831 |
1,843 |
||||||
Mineral leaseholds, net |
1,607 |
1,604 |
||||||
Intangible assets, net |
223 |
244 |
||||||
Inventories, net |
14 |
12 |
||||||
Other long-term assets |
22 |
23 |
||||||
Total assets |
$ 4,950 |
$ 5,027 |
||||||
LIABILITIES AND EQUITY |
||||||||
Current Liabilities |
||||||||
Accounts payable |
$ 181 |
$ 159 |
||||||
Accrued liabilities |
174 |
180 |
||||||
Short-term debt |
150 |
150 |
||||||
Long-term debt due within one year |
16 |
16 |
||||||
Income taxes payable |
1 |
43 |
||||||
Total current liabilities |
522 |
548 |
||||||
Noncurrent Liabilities |
||||||||
Long-term debt |
2,888 |
2,910 |
||||||
Pension and postretirement healthcare benefits |
122 |
141 |
||||||
Asset retirement obligations |
73 |
77 |
||||||
Long-term deferred tax liabilities |
152 |
143 |
||||||
Other long-term liabilities |
32 |
98 |
||||||
Total liabilities |
3,789 |
3,917 |
||||||
Contingencies and Commitments |
||||||||
Shareholders’ Equity |
||||||||
Tronox Limited Class A ordinary shares, par value |
1 |
1 |
||||||
Tronox Limited Class B ordinary shares, par value |
– |
– |
||||||
Capital in excess of par value |
1,524 |
1,500 |
||||||
Accumulated deficit / retained earnings |
(13) |
93 |
||||||
Accumulated other comprehensive loss |
(495) |
(596) |
||||||
Total shareholders’ equity |
1,017 |
998 |
||||||
Noncontrolling interest |
144 |
112 |
||||||
Total equity |
1,161 |
1,110 |
||||||
Total liabilities and equity |
$ 4,950 |
$ 5,027 |
|
|||
CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||
(UNAUDITED) |
|||
(Millions of |
|||
Year Ended |
|||
2016 |
2015 |
||
Cash Flows from Operating Activities: |
|||
Net loss |
|
|
|
Adjustments to reconcile net loss to net cash provided by operating activities: |
|||
Depreciation, depletion and amortization |
236 |
294 |
|
Tax impact of reorganization |
(107) |
– |
|
Deferred income taxes |
(9) |
– |
|
Share-based compensation expense |
25 |
22 |
|
Amortization of deferred debt issuance costs and discount on debt |
11 |
11 |
|
Pension and postretirement healthcare benefit expense |
8 |
5 |
|
Gain on extinguishment of debt |
(4) |
– |
|
Amortization of fair value inventory step-up |
– |
9 |
|
Other |
55 |
(4) |
|
Contributions to employee pension and postretirement plans |
(25) |
(17) |
|
Changes in assets and liabilities: |
|||
(Increase) decrease in accounts receivable |
(27) |
20 |
|
(Increase) decrease in inventories |
111 |
157 |
|
(Increase) decrease in prepaid and other assets |
(9) |
18 |
|
Increase (decrease) in accounts payable and accrued liabilities |
8 |
(12) |
|
Increase (decrease) in income taxes payable |
(4) |
20 |
|
Cash provided by operating activities |
211 |
216 |
|
Cash Flows from Investing Activities: |
|||
Capital expenditures |
(119) |
(191) |
|
Proceeds from the sale of assets |
2 |
1 |
|
Acquisition of business |
– |
(1,650) |
|
Cash used in investing activities |
(117) |
(1,840) |
|
Cash Flows from Financing Activities: |
|||
Repayments of debt |
(31) |
(18) |
|
Proceeds from debt |
– |
750 |
|
Debt issuance costs |
– |
(15) |
|
Dividends paid |
(46) |
(117) |
|
Proceeds from the exercise of warrants and options |
– |
3 |
|
Cash provided by (used in) financing activities |
(77) |
603 |
|
Effects of exchange rate changes on cash and cash equivalents |
2 |
(26) |
|
Net increase (decrease) in cash and cash equivalents |
19 |
(1,047) |
|
Cash and cash equivalents at beginning of period |
229 |
1,276 |
|
Cash and cash equivalents at end of period |
|
$ 229 |
|
|||||||||||||||
CONDENSED STATEMENT OF FREE CASH FLOWS (NON- |
|||||||||||||||
(UNAUDITED) |
|||||||||||||||
(Millions of |
|||||||||||||||
Three Months Ended |
Year Ended |
||||||||||||||
TiO2 |
Alkali |
Corporate |
Consolidated |
TiO2 |
Alkali |
Corporate |
Consolidated |
||||||||
Operating income (loss) ( |
$ 18 |
$ 30 |
$ (16) |
$ 32 |
$ 6 |
$ 84 |
$ (54) |
$ 36 |
|||||||
Depreciation, depletion and amortization expense |
44 |
15 |
2 |
61 |
171 |
59 |
6 |
236 |
|||||||
Other |
18 |
1 |
(7) |
12 |
59 |
6 |
(23) |
42 |
|||||||
Adjusted EBITDA (non- |
$ 80 |
$ 46 |
$ (21) |
$ 105 |
|
$ 149 |
$ (71) |
$ 314 |
|||||||
Adjusted EBITDA (non- |
$ 80 |
$ 46 |
$ (21) |
$ 105 |
|
$ 149 |
$ (71) |
$ 314 |
|||||||
Interest paid, net of capitalized interest and interest income |
– |
– |
(16) |
(16) |
– |
– |
(170) |
(170) |
|||||||
Income tax benefit |
– |
– |
144 |
144 |
– |
– |
115 |
115 |
|||||||
Contributions to employee pension and postretirement plans |
(4) |
(1) |
– |
(5) |
(19) |
(6) |
– |
(25) |
|||||||
Tax impact of reorganization |
– |
– |
(137) |
(137) |
– |
– |
(107) |
(107) |
|||||||
Deferred income taxes |
– |
– |
(5) |
(5) |
– |
– |
(9) |
(9) |
|||||||
Other |
8 |
10 |
(31) |
(13) |
28 |
10 |
(24) |
14 |
|||||||
Changes in assets and liabilities |
|||||||||||||||
(Increase) decrease in accounts receivable |
(18) |
(10) |
– |
(28) |
(21) |
(6) |
– |
(27) |
|||||||
(Increase) decrease in inventories |
13 |
– |
– |
13 |
107 |
4 |
– |
111 |
|||||||
(Increase) decrease in prepaid and other assets |
(3) |
(1) |
– |
(4) |
(8) |
(4) |
3 |
(9) |
|||||||
Increase (decrease) in accounts payable and accrued liabilities |
22 |
(11) |
25 |
36 |
20 |
(3) |
(9) |
8 |
|||||||
Increase (decrease) in income taxes payable |
– |
– |
(2) |
(2) |
– |
– |
(4) |
(4) |
|||||||
Subtotal |
14 |
(22) |
23 |
15 |
98 |
(9) |
(10) |
79 |
|||||||
Cash provided by (used in) operating activities ( |
98 |
33 |
(43) |
88 |
343 |
144 |
(276) |
211 |
|||||||
Capital expenditures |
(26) |
(5) |
(1) |
(32) |
(84) |
(33) |
(2) |
(119) |
|||||||
Free cash flow (non- |
$ 72 |
$ 28 |
$ (44) |
$ 56 |
|
$ 111 |
$ (278) |
$ 92 |
|
||||||||
RECONCILIATION OF NET LOSS TO EBITDA AND ADJUSTED EBITDA (NON- |
||||||||
(UNAUDITED) |
||||||||
(Millions of |
||||||||
Three Months Ended |
Year Ended |
|||||||
2016 |
2015 |
2016 |
2015 |
|||||
Net income (loss) ( |
|
|
|
|
||||
Interest and debt expense, net |
46 |
45 |
184 |
176 |
||||
Interest income |
(1) |
(2) |
(3) |
(7) |
||||
Income tax benefit (provision) |
(144) |
12 |
(115) |
41 |
||||
Depreciation, depletion and amortization expense |
61 |
72 |
236 |
294 |
||||
EBITDA (non- |
86 |
38 |
244 |
197 |
||||
Amortization of inventory step-up from purchase accounting (a) |
– |
– |
– |
9 |
||||
Alkali transaction costs (b) |
– |
– |
– |
29 |
||||
Share-based compensation (c) |
6 |
5 |
25 |
22 |
||||
Restructuring expense (d) |
(1) |
14 |
1 |
21 |
||||
Gain on extinguishment of debt (e) |
– |
– |
(4) |
– |
||||
Foreign currency remeasurement (f) |
– |
(5) |
32 |
(21) |
||||
Other items (g) |
14 |
8 |
16 |
15 |
||||
Adjusted EBITDA (non- |
|
$ 60 |
|
$ 272 |
||||
(a) Amortization of inventory step-up from purchase accounting related to the acquisition of the Alkali business which is included in “Cost of goods sold” in the unaudited Condensed Consolidated Statements of Operations. |
||||||||
(b) One-time non-operating items and the effect of acquisition which is included in “Selling, general and administrative expenses” in the unaudited Condensed Consolidated Statements of Operations. |
||||||||
(c) Represents non-cash share-based compensation. |
||||||||
(d) Represents severance and other costs associated with the shutdown of our sodium chlorate plant, and other global |
||||||||
(e) Represents the gain associated with the repurchase of |
||||||||
(f) Represents foreign currency remeasurement which is included in “Other income (expense), net” in the unaudited Condensed Consolidated Statements of Operations. |
||||||||
(g) Includes noncash pension and postretirement costs, severance expense, adjustment of transfer tax related to the Exxaro Transaction, insurance settlement gain, and other items included in “Selling general and administrative expenses” and “Cost of goods sold” in the unaudited Condensed Consolidated Statements of Operations. |
||||||||
(h) No income tax impact given full valuation allowance except for |
||||||||
The following table reconciles income (loss) from operations, the comparable measure for segment reporting under |
||||||||
Three Months Ended |
Year Ended |
|||||||
2016 |
2015 |
2016 |
2015 |
|||||
Tio2 segment |
18 |
(65) |
6 |
(123) |
||||
Alkali segment |
30 |
23 |
84 |
69 |
||||
Corporate |
(16) |
4 |
(54) |
(64) |
||||
Income (loss) from operations ( |
32 |
(38) |
36 |
(118) |
||||
Tio2 segment |
44 |
57 |
171 |
246 |
||||
Alkali segment |
15 |
14 |
59 |
42 |
||||
Corporate |
2 |
1 |
6 |
6 |
||||
Depreciation, depletion and amortization expense |
61 |
72 |
236 |
294 |
||||
Tio2 segment |
18 |
44 |
59 |
92 |
||||
Alkali segment |
1 |
1 |
6 |
18 |
||||
Corporate |
(7) |
(19) |
(23) |
(14) |
||||
Other |
12 |
26 |
42 |
96 |
||||
Tio2 segment |
80 |
36 |
236 |
215 |
||||
Alkali segment |
46 |
38 |
149 |
129 |
||||
Corporate |
(21) |
(14) |
(71) |
(72) |
||||
Adjusted EBITDA (non- |
|
$ 60 |
|
$ 272 |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tronox-reports-fourth-quarter-and-full-year-2016-financial-results-300410234.html
SOURCE
News Provided by Acquire Media